Reported covered position: Hlth pol advsr, Chrmn Harkin, Sen Comm on Hlth Ed Lbr & Pnsns, Mar 2013 - Apr 3, 2014
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Preserving Patient Access to Compounded Medications Act of 2017
Client: UNITED STATES PHARMACOPEIAL CONVENTION · Firm: AKIN GUMP STRAUSS HAUER & FELD
FDA and NIH Workforce Authorities Modernization Act; FDA User Fee re authorization legislation; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017; OTC monograph legislation; compounding; opioids.
Over-the-Counter Hearing Aid Act of 2017
Client: AMPLIFON (USA), INC. · Firm: AKIN GUMP STRAUSS HAUER & FELD
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
CONTRACEPTION ACCESS INITIATIVE via AKIN GUMP STRAUSS HAUER & FELD
2026 · third_quarter · RR
Issues related to FDA review of over-the-counter contraception.
UNITED STATES PHARMACOPEIAL CONVENTION via AKIN GUMP STRAUSS HAUER & FELD
2018 · first_quarter · Q1
Source: Senate LDA
| AMPLIFON (USA), INC. |
| 4 |
| 2017 |
| ALLIANCE OF DEDICATED CANCER CENTERS | 1 | 2016 |
| CONTRACEPTION ACCESS INITIATIVE | 1 | 2026 |
| ResMed Corp. | 1 | 2016 |
Regulation of hearing aids; S. 670; H.R. 1652.
Over-the-Counter Hearing Aid Act of 2017
Client: AMPLIFON (USA), INC. · Firm: AKIN GUMP STRAUSS HAUER & FELD
Regulation of hearing aids; S. 670; H.R. 1652.
Over-the-Counter Hearing Aid Act of 2017
Client: AMPLIFON (USA), INC. · Firm: AKIN GUMP STRAUSS HAUER & FELD
Regulation of hearing aids; S. 670; H.R. 1652.
Over-the-Counter Hearing Aid Act of 2017
Client: AMPLIFON (USA), INC. · Firm: AKIN GUMP STRAUSS HAUER & FELD
Regulation of hearing aids; S. 670; H.R. 1652.
FDA Reauthorization Act of 2017
Client: MEDTRONIC INC · Firm: AKIN GUMP STRAUSS HAUER & FELD
H.R. 2430/S.934-FDA Reauthorization Act of 2017.
FDA Reauthorization Act of 2017
Client: MEDTRONIC INC · Firm: AKIN GUMP STRAUSS HAUER & FELD
H.R. 2430/S.934-FDA Reauthorization Act of 2017.
FDA Reauthorization Act of 2017
Client: MEDTRONIC INC · Firm: AKIN GUMP STRAUSS HAUER & FELD
H.R. 2430/S.934-FDA Reauthorization Act of 2017.
Preserving Patient Access to Compounded Medications Act of 2017
Client: UNITED STATES PHARMACOPEIAL CONVENTION · Firm: AKIN GUMP STRAUSS HAUER & FELD
FDA and NIH Workforce Authorities Modernization Act; FDA User Fee re authorization legislation; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017; OTC monograph legislation.
Preserving Patient Access to Compounded Medications Act of 2017
Client: UNITED STATES PHARMACOPEIAL CONVENTION · Firm: AKIN GUMP STRAUSS HAUER & FELD
FDA and NIH Workforce Authorities Modernization Act; FDA User Fee re authorization legislation; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017; OTC monograph legislation.
Preserving Patient Access to Compounded Medications Act of 2017
Client: UNITED STATES PHARMACOPEIAL CONVENTION · Firm: AKIN GUMP STRAUSS HAUER & FELD
FDA and NIH Workforce Authorities Modernization Act; FDA User Fee re authorization legislation; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Over-the-Counter Hearing Aid Act of 2017
Client: AMPLIFON (USA), INC. · Firm: AKIN GUMP STRAUSS HAUER & FELD
Regulation of hearing aids; S. 670; H.R. 1652.
Over-the-Counter Hearing Aid Act of 2017
Client: AMPLIFON (USA), INC. · Firm: AKIN GUMP STRAUSS HAUER & FELD
Regulation of hearing aids; S. 670; H.R. 1652.
Over-the-Counter Hearing Aid Act of 2017
Client: AMPLIFON (USA), INC. · Firm: AKIN GUMP STRAUSS HAUER & FELD
Regulation of hearing aids; S. 670; H.R. 1652.
Over-the-Counter Hearing Aid Act of 2017
Client: AMPLIFON (USA), INC. · Firm: AKIN GUMP STRAUSS HAUER & FELD
Regulation of hearing aids; S. 670; H.R. 1652.
H.R. 2430/S.934-FDA Reauthorization Act of 2017.
H.R. 2430/S.934-FDA Reauthorization Act of 2017.
H.R. 2430/S.934-FDA Reauthorization Act of 2017.
Osteoarthritis advocacy; 21st Century Cures Act (H.R. 34).
Osteoarthritis advocacy; 21st Century Cures Act (H.R. 34).
Osteoarthritis advocacy; 21st Century Cures Act (H.R. 34).
Osteoarthritis advocacy; 21st Century Cures Act (H.R. 6)
FDA and NIH Workforce Authorities Modernization Act
Client: UNITED STATES PHARMACOPEIAL CONVENTION · Firm: AKIN GUMP STRAUSS HAUER & FELD
FDA and NIH Workforce Authorities Modernization Act, S. 2700.
FDA and NIH Workforce Authorities Modernization Act
Client: UNITED STATES PHARMACOPEIAL CONVENTION · Firm: AKIN GUMP STRAUSS HAUER & FELD
FDA and NIH Workforce Authorities Modernization Act, S. 2700.
FDA and NIH Workforce Authorities Modernization Act
Client: UNITED STATES PHARMACOPEIAL CONVENTION · Firm: AKIN GUMP STRAUSS HAUER & FELD
FDA and NIH Workforce Authorities Modernization Act, S. 2700.
FDA and NIH Workforce Authorities Modernization Act
Client: UNITED STATES PHARMACOPEIAL CONVENTION · Firm: AKIN GUMP STRAUSS HAUER & FELD
FDA and NIH Workforce Authorities Modernization Act, S. 2700.
FDA and NIH Workforce Authorities Modernization Act; FDA User Fee re authorization legislation; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017; OTC monograph legislation; compounding; opioids.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDTRONIC INC via AKIN GUMP STRAUSS HAUER & FELD
2017 · fourth_quarter · Q4
H.R. 2430/S.934-FDA Reauthorization Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED STATES PHARMACOPEIAL CONVENTION via AKIN GUMP STRAUSS HAUER & FELD
2017 · fourth_quarter · Q4
FDA and NIH Workforce Authorities Modernization Act; FDA User Fee re authorization legislation; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017; OTC monograph legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMPLIFON (USA), INC. via AKIN GUMP STRAUSS HAUER & FELD
2017 · fourth_quarter · 4T
Regulation of hearing aids; S. 670; H.R. 1652.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDTRONIC INC via AKIN GUMP STRAUSS HAUER & FELD
2017 · third_quarter · Q3
H.R. 2430/S.934-FDA Reauthorization Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED STATES PHARMACOPEIAL CONVENTION via AKIN GUMP STRAUSS HAUER & FELD
2017 · third_quarter · Q3
FDA and NIH Workforce Authorities Modernization Act; FDA User Fee re authorization legislation; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017; OTC monograph legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMPLIFON (USA), INC. via AKIN GUMP STRAUSS HAUER & FELD
2017 · third_quarter · Q3
Regulation of hearing aids; S. 670; H.R. 1652.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAMUMED, LLC via AKIN GUMP STRAUSS HAUER & FELD
2017 · second_quarter · Q2
Sourcing of income issue.
Osteoarthritis advocacy; 21st Century Cures Act (H.R. 34).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED STATES PHARMACOPEIAL CONVENTION via AKIN GUMP STRAUSS HAUER & FELD
2017 · second_quarter · Q2
FDA and NIH Workforce Authorities Modernization Act; FDA User Fee re authorization legislation; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FOUNDATION MEDICINE, INC. via AKIN GUMP STRAUSS HAUER & FELD
2017 · second_quarter · 2T
Congressional and regulatory advocacy for Medicare coverage of new technology.
Medicare coverage of new technology; regulation of diagnostics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMPLIFON (USA), INC. via AKIN GUMP STRAUSS HAUER & FELD
2017 · second_quarter · Q2
Regulation of hearing aids; S. 670; H.R. 1652.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDTRONIC INC via AKIN GUMP STRAUSS HAUER & FELD
2017 · second_quarter · Q2
H.R. 2430/S.934-FDA Reauthorization Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDTRONIC INC via AKIN GUMP STRAUSS HAUER & FELD
2017 · first_quarter · Q1
Medical device regulatory reforms.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAMUMED, LLC via AKIN GUMP STRAUSS HAUER & FELD
2017 · first_quarter · Q1
Osteoarthritis advocacy; 21st Century Cures Act (H.R. 34).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED STATES PHARMACOPEIAL CONVENTION via AKIN GUMP STRAUSS HAUER & FELD
2017 · first_quarter · Q1
FDA and NIH Workforce Authorities Modernization Act; FDA User Fee re authorization legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FOUNDATION MEDICINE, INC. via AKIN GUMP STRAUSS HAUER & FELD
2017 · first_quarter · Q1
Congressional and regulatory advocacy for Medicare coverage of new technology.
Medicare coverage of new technology; regulation of diagnostics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMPLIFON (USA), INC. via AKIN GUMP STRAUSS HAUER & FELD
2017 · first_quarter · Q1
Regulation of hearing aids; S. 670; H.R. 1652.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDTRONIC INC via AKIN GUMP STRAUSS HAUER & FELD
2016 · fourth_quarter · Q4
Medical device regulatory reforms
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAMUMED, LLC via AKIN GUMP STRAUSS HAUER & FELD
2016 · fourth_quarter · Q4
Osteoarthritis advocacy; 21st Century Cures Act (H.R. 34).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED STATES PHARMACOPEIAL CONVENTION via AKIN GUMP STRAUSS HAUER & FELD
2016 · fourth_quarter · Q4
FDA and NIH Workforce Authorities Modernization Act, S. 2700.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FOUNDATION MEDICINE, INC. via AKIN GUMP STRAUSS HAUER & FELD
2016 · fourth_quarter · Q4
Congressional and regulatory advocacy for Medicare coverage of new technology
Medicare coverage of new technology; regulation of diagnostics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE OF DEDICATED CANCER CENTERS via AKIN GUMP STRAUSS HAUER & FELD
2016 · fourth_quarter · Q4
Medicare reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDTRONIC INC via AKIN GUMP STRAUSS HAUER & FELD
2016 · third_quarter · Q3
Medical device regulatory reforms
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FDA ACCOUNT MANAGEMENT COALITION via AKIN GUMP STRAUSS HAUER & FELD
2016 · third_quarter · Q3
Support adoption of account management practices at FDA
Support adoption of account management practices at FDA
Filing targets: Food & Drug Administration (FDA)
FOUNDATION MEDICINE, INC. via AKIN GUMP STRAUSS HAUER & FELD
2016 · third_quarter · Q3
Congressional and regulatory advocacy for Medicare coverage of new technology
Medicare coverage of new technology; regulation of diagnostics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED STATES PHARMACOPEIAL CONVENTION via AKIN GUMP STRAUSS HAUER & FELD
2016 · third_quarter · Q3
FDA and NIH Workforce Authorities Modernization Act, S. 2700.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAMUMED, LLC via AKIN GUMP STRAUSS HAUER & FELD
2016 · third_quarter · Q3
Osteoarthritis advocacy; 21st Century Cures Act (H.R. 6)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FOUNDATION MEDICINE, INC. via AKIN GUMP STRAUSS HAUER & FELD
2016 · second_quarter · Q2
Congressional and regulatory advocacy for Medicare coverage of new technology
Congressional and regulatory advocacy for Medicare coverage of new technology
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED STATES PHARMACOPEIAL CONVENTION via AKIN GUMP STRAUSS HAUER & FELD
2016 · second_quarter · Q2
FDA and NIH Workforce Authorities Modernization Act, S. 2700.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FDA ACCOUNT MANAGEMENT COALITION via AKIN GUMP STRAUSS HAUER & FELD
2016 · second_quarter · Q2
Support adoption of account management practices at FDA
Support adoption of account management practices at FDA
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
SAMUMED, LLC via AKIN GUMP STRAUSS HAUER & FELD
2016 · second_quarter · Q2
Osteoarthritis advocacy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDTRONIC INC via AKIN GUMP STRAUSS HAUER & FELD
2016 · second_quarter · Q2
Medical device regulatory reforms
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED STATES PHARMACOPEIAL CONVENTION via AKIN GUMP STRAUSS HAUER & FELD
2016 · second_quarter · RR
FDA and NIH Workforce Authorities Modernization Act, S. 2700.
FDA ACCOUNT MANAGEMENT COALITION via AKIN GUMP STRAUSS HAUER & FELD
2016 · first_quarter · Q1
Support adoption of account management practices at FDA
Support adoption of account management practices at FDA
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
SAMUMED, LLC via AKIN GUMP STRAUSS HAUER & FELD
2016 · first_quarter · Q1
Osteoarthritis advocacy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FOUNDATION MEDICINE, INC. via AKIN GUMP STRAUSS HAUER & FELD
2016 · first_quarter · Q1
Congressional and regulatory advocacy for Medicare coverage of new technology
Congressional and regulatory advocacy for Medicare coverage of new technology
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDTRONIC INC via AKIN GUMP STRAUSS HAUER & FELD
2016 · first_quarter · Q1
Medical device regulatory reforms
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MATCHRX via AKIN GUMP STRAUSS HAUER & FELD
2016 · first_quarter · Q1
Implementation of Drug Quality and Security Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RESMED CORP. via AKIN GUMP STRAUSS HAUER & FELD
2016 · first_quarter · RR
FDA reform legislation; telemonitoring; competitive bidding.
FDA ACCOUNT MANAGEMENT COALITION via AKIN GUMP STRAUSS HAUER & FELD
2015 · fourth_quarter · Q4
Support adoption of account management practices at FDA
Support adoption of account management practices at FDA
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
SAMUMED, LLC via AKIN GUMP STRAUSS HAUER & FELD
2015 · fourth_quarter · Q4
Osteoarthritis advocacy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FOUNDATION MEDICINE, INC. via AKIN GUMP STRAUSS HAUER & FELD
2015 · fourth_quarter · Q4
Congressional and regulatory advocacy for Medicare coverage of new technology
Congressional and regulatory advocacy for Medicare coverage of new technology
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDTRONIC INC via AKIN GUMP STRAUSS HAUER & FELD
2015 · fourth_quarter · Q4
Medical device regulatory reforms
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MATCHRX via AKIN GUMP STRAUSS HAUER & FELD
2015 · fourth_quarter · Q4
Implementation of Drug Quality and Security Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FDA ACCOUNT MANAGEMENT COALITION via AKIN GUMP STRAUSS HAUER & FELD
2015 · fourth_quarter · RR
Support adoption of account management practices at FDA
Support adoption of account management practices at FDA
SAMUMED, LLC via AKIN GUMP STRAUSS HAUER & FELD
2015 · third_quarter · Q3
Osteoarthritis advocacy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FOUNDATION MEDICINE, INC. via AKIN GUMP STRAUSS HAUER & FELD
2015 · third_quarter · Q3
Congressional and regulatory advocacy for Medicare coverage of new technology
Congressional and regulatory advocacy for Medicare coverage of new technology
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDTRONIC INC via AKIN GUMP STRAUSS HAUER & FELD
2015 · third_quarter · Q3
Medical device regulatory reforms
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MATCHRX via AKIN GUMP STRAUSS HAUER & FELD
2015 · third_quarter · Q3
Implementation of Drug Quality and Security Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAMUMED, LLC via AKIN GUMP STRAUSS HAUER & FELD
2015 · second_quarter · Q2
Osteoarthritis advocacy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDTRONIC INC via AKIN GUMP STRAUSS HAUER & FELD
2015 · second_quarter · Q2
Medical device regulatory reforms
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MATCHRX via AKIN GUMP STRAUSS HAUER & FELD
2015 · second_quarter · Q2
Implementation of Drug Quality and Security Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FOUNDATION MEDICINE, INC. via AKIN GUMP STRAUSS HAUER & FELD
2015 · second_quarter · RR
Congressional and regulatory advocacy for Medicare coverage of new technology
Congressional and regulatory advocacy for Medicare coverage of new technology
SAMUMED, LLC via AKIN GUMP STRAUSS HAUER & FELD
2015 · second_quarter · RR
Osteoarthritis advocacy
MATCHRX via AKIN GUMP STRAUSS HAUER & FELD
2015 · second_quarter · RR
Implementation of Drug Quality and Security Act